These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24828271)

  • 1. The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: the modeling approach.
    Suthar AB; Bui DD; Granich RM; Nadol P; Tran HV; Sabin K; Williams BG; Lo YR; Kato M
    J Acquir Immune Defic Syndr; 2014 Jun; 66(2):e62-3. PubMed ID: 24828271
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessing the Public Health impact of HIV interventions: the critical role of demographics.
    Dimitrov D; Kuang Y; Mâsse BR
    J Acquir Immune Defic Syndr; 2014 Jun; 66(2):e60-2. PubMed ID: 24828270
    [No Abstract]   [Full Text] [Related]  

  • 3. The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: towards elimination of HIV transmission.
    Kato M; Granich R; Bui DD; Tran HV; Nadol P; Jacka D; Sabin K; Suthar AB; Mesquita F; Lo YR; Williams B
    J Acquir Immune Defic Syndr; 2013 Aug; 63(5):e142-9. PubMed ID: 23714739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dean Street clinics-battling London's MSM HIV epidemic.
    Kirby T; Thornber-Dunwell M
    Lancet HIV; 2018 May; 5(5):e210. PubMed ID: 29739698
    [No Abstract]   [Full Text] [Related]  

  • 5. Why Everyone (Almost) with HIV Needs to Be on Treatment: A Review of the Critical Data.
    Farel CE; Dennis AM
    Infect Dis Clin North Am; 2019 Sep; 33(3):663-679. PubMed ID: 31248703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of HIV transmission under combined antiretroviral therapy: toward risk zero?
    Supervie V; Viard JP; Costagliola D; Breban R
    J Acquir Immune Defic Syndr; 2015 Mar; 68(3):e41-2. PubMed ID: 25469531
    [No Abstract]   [Full Text] [Related]  

  • 7. CROI 2014: Advances in antiretroviral therapy.
    Taylor BS; Shalev N; Wilkin TJ
    Top Antivir Med; 2014 May; 22(2):616-31. PubMed ID: 24901887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does antiretroviral therapy prevent HIV transmission to sexual partners?
    Lalani T; Hicks C
    Curr HIV/AIDS Rep; 2007 May; 4(2):80-5. PubMed ID: 17547829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of HIV-1 infection with antiretroviral therapy.
    Tao X; Shao D; Xue W
    N Engl J Med; 2011 Nov; 365(20):1934-5; author reply 1935. PubMed ID: 22087689
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of HIV-1 infection with antiretroviral therapy.
    Rodger A; Phillips A; Lundgren J
    N Engl J Med; 2011 Nov; 365(20):1934; author reply 1935. PubMed ID: 22087688
    [No Abstract]   [Full Text] [Related]  

  • 11. Scale-up of combination prevention and antiretroviral therapy for female sex workers in West Africa: time for action.
    Alary M; Lowndes CM; Van de Perre P; Béhanzin L; Batona G; Guédou FA; Konate I; Traore I; Asamoah-Adu C; Akinocho E; Nagot N
    AIDS; 2013 Jun; 27(9):1369-74. PubMed ID: 23945501
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiretroviral therapy for naïve and for treatment-experienced HIV patients, and prevention of HIV transmission.
    Antunes F
    Curr Opin HIV AIDS; 2011 Dec; 6 Suppl 1():S1-2. PubMed ID: 22156774
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.
    Anglemyer A; Horvath T; Rutherford G
    JAMA; 2013 Oct; 310(15):1619-20. PubMed ID: 24129466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highlights on HIV eradication in 2013.
    Monforte Ad; Svicher V; Nozza S; Lazzarin A; Marchetti G; Perno CF
    AIDS; 2014 Jan; 28(1):1-7. PubMed ID: 23939240
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1.
    Pinnetti C; Tintoni M; Ammassari A; Tamburrini E; Bernardi S; Liuzzi G; Scambia G; Perno CF; Floridia M; Antinori A; Cavaliere AF
    AIDS; 2015 Nov; 29(18):2534-7. PubMed ID: 26372490
    [No Abstract]   [Full Text] [Related]  

  • 16. Adherence to Early Antiretroviral Therapy: Results From HPTN 052, a Phase III, Multinational Randomized Trial of ART to Prevent HIV-1 Sexual Transmission in Serodiscordant Couples.
    Safren SA; Mayer KH; Ou SS; McCauley M; Grinsztejn B; Hosseinipour MC; Kumarasamy N; Gamble T; Hoffman I; Celentano D; Chen YQ; Cohen MS;
    J Acquir Immune Defic Syndr; 2015 Jun; 69(2):234-40. PubMed ID: 26009832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing HIV transmission with antiretrovirals.
    De Cock KM; Crowley SP; Lo YR; Granich RM; Williams BG
    Bull World Health Organ; 2009 Jul; 87(7):488-488A. PubMed ID: 19649357
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV/AIDS.
    Saag MS; Masur H
    Infect Dis Clin North Am; 2014 Sep; 28(3):xv-xvi. PubMed ID: 25151570
    [No Abstract]   [Full Text] [Related]  

  • 19. The 20th International AIDS Conference: where do we go from here?
    Wainberg MA; Kippax S; Bras M; Salif Sow P
    J Int AIDS Soc; 2014; 17(1):19331. PubMed ID: 25043381
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV-2 down, HIV-1 to go? Understanding the possibilities of treatment as prevention.
    Bruhn CA; Gilbert MT
    Lancet Infect Dis; 2011 Apr; 11(4):260-1. PubMed ID: 21453865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.